JW Pharmaceutical Corporation
001065.KS
Get informed when a big investor buys or sells
+ FollowMarket Cap$608.52B
Close$
Share Statistics
| Market cap | $608.52 Billion |
|---|---|
| Enterprise Value | $636.12 Billion |
| Dividend Yield | $675.00 (2.47%) |
| Earnings per Share | $2534.75 |
| Beta | 0.96 |
| Outstanding Shares | 23,628,000 |
Return
| Return on Equity | 24.71% |
|---|---|
| Return on Assets | 15.35% |
| Return on Invested Capital | 24.19% |
Valuation & Multiples
| P/E Ratio | 6.28 |
|---|---|
| PEG | -0.39 |
| Price to Sales | 0.61 |
| Price to Book Ratio | 1.23 |
| Enterprise Value to Revenue | 0.78 |
| Enterprise Value to EBIT | 5.99 |
| Enterprise Value to Net Income | 6 |
| Total Debt to Enterprise | 0.11 |
| Debt to Equity | 0.18 |
Revenue Sources
No data
Insider Trades
Next Earnings Call
Expected Date
November 18, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About JW Pharmaceutical Corporation
1,106 employees
CEO: Young-Sub Shin JW Pharmaceutical Corporation, established in 1945 and headquartered in Seoul, South Korea, operates globally, focusing on the development, manufacturing, and distribution of a comprehensive range of pharmaceuticals and medical supplies....